In both the c‐myc‐amplified Non‐WNT/Non‐SHH medulloblastoma cell lines, an additive cytoreductive effect of GDC‐0941 is noticeable when combined with 1 and 2 μM Axitinib. The gene discussed is MYC; the disease is medulloblastoma.